VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

NCT03373188 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colon Carcinoma Metastatic in the Liver
Colorectal Adenocarcinoma
Pancreatic Adenocarcinoma
Resectable Pancreatic Carcinoma
Stage I Pancreatic Cancer
Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage II Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Colorectal Cancer
Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer

Interventions

BIOLOGICAL: Anti-SEMA4D Monoclonal Antibody VX15/2503
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
PROCEDURE: Surgery

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]